Wolverine Asset Management »

Bridgebio Pharma shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 14M 1.21
2022-03-31 $34M 58M 0.59
2021-12-31 $61M 83M 0.73
2021-09-30 $114M 83M 1.38
2021-06-30 $119M 73M 1.64
2021-03-31 $110M 67M 1.65

More positions owned by Wolverine Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ati Note 3.500% 6/1 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Amazon Call Option (AMZN)
Royal Caribbean Cruises Put Option (RCL)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
NVIDIA Corporation Call Option (NVDA)
Li Auto Note 0.250% 5/0 (Principal)
Draftkings Note 3/1 (Principal)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)

View all positions for Wolverine Asset Management

Top funds holding Bridgebio Pharma

Braidwell
Graham Capital Management
Aristeia Capital
D. E. Shaw & Co
Point72 Asset Management
Wells Fargo & Company
Lazard Asset Management
683 Capital Management
MacKay Shields
Wolverine Asset Management
Lord, Abbett & Co
Calamos Advisors
Weiss Asset Management LP[1
Ubs Global Asset Management Americas
SSI Investment Management

View all funds holding Bridgebio Pharma